HIGHLIGHTS
- who: He Li and collaborators from the Southeast University, China have published the paper: A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy, in the Journal: (JOURNAL)
- what: The study showed a statistically significant increase in CD274 expression in IMvigor210 and GBMcohort datasets in SKCM, TGCT, ACC, and THYM compared to normal tissues. Specifically, the study explored more the potential roles of CD161 in the tumor microenvironment of melanoma at the single-cell_sequencing level and the prediction of transcription factors.
- how: The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.